Skip to main content

Thrombogenicity Indices and Coronary Microvascular Dysfunction in Patients

Despite recent breakthroughs in procedural and pharmacologic methods, acute myocardial infarction (AMI) is one of the leading causes of death and is linked with substantial morbidity. In patients with AMI, the focus has been on prompt reperfusion of the epicardial coronary artery throughout the last few decades. Reduced myocardial perfusion has been linked to severe myocardial infarction, which results in negative left ventricular remodeling and higher cardiac mortality.


Effect of Del Nido cardioplegia on ventricular arrhythmias after cardiovascular surgery

Cardiopulmonary bypass (CPB) relies on cardiac cardioplegia to maintain the beating heart and provide surgeons with a reversible bloodless surgical field of vision. Del Nido cardioplegia (DNC) is a type of cold blood cardioplegia with a greater potassium level. Professor Pedro Del Nido at the University of Pittsburgh first created it for usage in children's underdeveloped myocardium. Despite the above-mentioned findings, DNC's application in adult patients is currently limited.


Assessing The Impact of Diversity and Aging Population on Health Expenditure of United States

With continued growth in healthcare services, aging and diversity have increased healthcare expenditure in the United States. For instance, the aged people spending on health treatments are similar to unhealthy young people's health spending throughout their lifetime. Besides, the rise in healthcare spending has been influenced by the increase in the population of the elderly in the United States.


Anticoagulation with Argatroban in a Patient with Heparin-Induced Thrombocytopenia

Heparin-induced thrombocytopenia is a risky immune-mediated condition that causes extensive thrombosis in people exposed to unfractionated heparin after undergoing heart surgery. The level of reduction of platelet count is a crucial risk element in the increase of thrombosis. Hemorrhage is not prevalent in such patients, and any noticeable thrombocytopenia is caused by eliminating antibody-coated platelets. The purpose of the study investigated by Green et al.


GE Healthcare Receives FDA Clearance for First Artificial Intelligence (AI) Algorithm

GE Healthcare today announced it has received Food and Drug Administration (FDA) approval for an artificial intelligence (AI) algorithm to help clinicians assess Endotracheal Tube (ETT) placements. The AI solution is one of five included in GE Healthcare’s Critical Care Suite 2.0, an industry-first collection of AI algorithms embedded on a mobile x-ray device for automated measurements, case prioritization and quality control.